Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Biomaterials|January 8, 2017
Nanoparticles for radiooncology: Mission, vision, challengesLeoni A Kunz-Schughart, Anna Dubrovska, Claudia Peitzsch, et al.
International Journal of Cancer|February 3, 2023
Dynamics of CXCR4 positive circulating tumor cells in prostate cancer patients during radiotherapyDaria Klusa, Fabian Lohaus, Andre Franken, et al.
Cancer Research|March 18, 2016
An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer CellsClaudia Peitzsch, Monica Cojoc, Linda Hein, et al.
Oncoimmunology|May 20, 2020
UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cellsClaudia Arndt, Liliana R Loureiro, Anja Feldmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2019
The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma RadiosensitivityDavid Digomann, Ina Kurth, Anna Tyutyunnykova, et al.
Theranostics|January 3, 2024
ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcriptionIelizaveta Gorodetska, Anne Offermann, Jakob Püschel, et al.
Cancers|May 6, 2020
The Role of lncRNAs TAPIR-1 and -2 as Diagnostic Markers and Potential Therapeutic Targets in Prostate CancerMaik Friedrich, Karolin Wiedemann, Kristin Reiche, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 24, 2025
Blood-based detection of MMP11 as a marker of prostate cancer progression regulated by the ALDH1A1-TGF-β1 signaling mechanismIelizaveta Gorodetska, Vasyl Lukiyanchuk, Marta Gawin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2016
Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROGAnnett Linge, Steffen Löck, Volker Gudziol, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2016
HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)Annett Linge, Fabian Lohaus, Steffen Löck, et al.
Pageof 10